AP

Active Director Director DIN 08085797
DIN 08085797 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankur Pal

Data last updated:

Ankur Pal is a Director at Waycross Pharmaceuticals Private Limited (since 2025) and Director at Villkon Pharma Private Limited (since 2018). The companies operate in Pharma and Trading.

DIN 08085797
Primary Designation Director
Industry Pharma
First Appointment 14 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20252025Active
Villkon Pharma Private Limited U51909DL2018PTC330870
Director14 Mar 20182018Under Process Of Striking Off

Directorship timeline

Open interactive timeline →
Waycross Pharmaceuticals Private Limited
Villkon Pharma Private Limited
Premium access

Shareholding and investment profile for Ankur Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Pal

Ankur Pal currently holds 2 directorships: Waycross Pharmaceuticals Private Limited (Director, since 07 Apr 2025); Villkon Pharma Private Limited (Director, since 14 Mar 2018).

Ankur Pal was first appointed on 14 Mar 2018 as Director at Villkon Pharma Private Limited. The most recent appointment on record is 07 Apr 2025 at Waycross Pharmaceuticals Private Limited.

The current boards of Ankur Pal's companies include Bachchu Sharma (Waycross Pharmaceuticals Private Limited), Ram Nath Shaw (Waycross Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available